A Simple and Effective Evidence-based Approach to Asthma Management: ICS-formoterol Reliever Therapy
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Levy M, Capstick T, Antalffy T Br J Gen Pract. 2024; 74(745):374-376.
PMID: 39054088 PMC: 11299697. DOI: 10.3399/bjgp24X739089.
Foot H, Chan A, Horne R Front Pharmacol. 2024; 15:1351851.
PMID: 39005938 PMC: 11239962. DOI: 10.3389/fphar.2024.1351851.
References
1.
Sobieraj D, Weeda E, Nguyen E, Coleman C, White C, Lazarus S
. Association of Inhaled Corticosteroids and Long-Acting β-Agonists as Controller and Quick Relief Therapy With Exacerbations and Symptom Control in Persistent Asthma: A Systematic Review and Meta-analysis. JAMA. 2018; 319(14):1485-1496.
PMC: 5876810.
DOI: 10.1001/jama.2018.2769.
View
2.
Keeley D, Baxter N
. Conflicting asthma guidelines cause confusion in primary care. BMJ. 2018; 360:k29.
DOI: 10.1136/bmj.k29.
View
3.
Rogliani P, Ritondo B, Ora J, Cazzola M, Calzetta L
. SMART and as-needed therapies in mild-to-severe asthma: a network meta-analysis. Eur Respir J. 2020; 56(3).
DOI: 10.1183/13993003.00625-2020.
View
4.
McKibben S, Bush A, Thomas M, Griffiths C
. "Tossing a coin:" defining the excessive use of short-acting beta-agonists in asthma-the views of general practitioners and asthma experts in primary and secondary care. NPJ Prim Care Respir Med. 2018; 28(1):26.
PMC: 6052065.
DOI: 10.1038/s41533-018-0096-4.
View
5.
Suissa S, Ernst P, Boivin J, Horwitz R, Habbick B, Cockroft D
. A cohort analysis of excess mortality in asthma and the use of inhaled beta-agonists. Am J Respir Crit Care Med. 1994; 149(3 Pt 1):604-10.
DOI: 10.1164/ajrccm.149.3.8118625.
View